Side by sideLilly (LLY) and Amgen (AMGN)Memos of October 10, 2026 and October 13, 2026
Lilly vs Amgen stock: the numbers side by side (October 2026)
How do Lilly and Amgen compare?
| Lilly LLY | Amgen AMGN | |
|---|---|---|
| Revenue growth | 44.7%Year to Dec 2025 | 10.0%2025 |
| Operating margin | 40.4%Year to Dec 2025 | 24.7%2025 |
| Free cash flow | 8,972US$ millions · Year to Dec 2025 | 8,100US$ millions · 2025 |
| Free cash flow yield | 1.7%Today (Oct 8, 2026) | 3.6%Today (Oct 12, 2026) |
| Dividend yield | 0.6%Today (Oct 8, 2026) | 2.4%Today (Oct 12, 2026) |
| P/E, last 12 months | 39.3xToday (Oct 8, 2026) | 26.0xToday (Oct 12, 2026) |
| P/E, next 12 months | 24.9xToday (Oct 8, 2026) | 17.1xToday (Oct 12, 2026) |
| Weighted price forecast, about 1 year | 1143.18 (-2 %)October 2027 | 519.76 (+27 %)October 2027 |
| Weighted price forecast, about 3 years | 1299.88 (+13 %)October 2029 | 548.42 (+39 %)October 2029 |
Who leads on what?
| Leads | The lead is | |
|---|---|---|
| Revenue growth | Lilly | The higher figure |
| Operating margin | Lilly | The higher figure |
| Free cash flow | Lilly | The higher figure |
| Free cash flow yield | Amgen | The higher figure |
| Dividend yield | Amgen | The higher figure |
| P/E, last 12 months | Amgen | The lower figure |
| P/E, next 12 months | Amgen | The lower figure |
| Weighted price forecast, about 1 year | Amgen | The higher weighted return |
| Weighted price forecast, about 3 years | Amgen | The higher weighted return |
What does each company do?
Lilly discovers, makes and sells prescription medicines for diabetes, chronic weight management, cancer, inflammatory disease, migraine, Alzheimer’s disease and osteoporosis.
Lilly (LLY), from our memo of October 10, 2026 · Lilly stock forecast
Amgen develops, makes and sells prescription medicines for bone, cardiovascular, inflammatory, cancer, rare-disease and other conditions.
Amgen (AMGN), from our memo of October 13, 2026 · Amgen stock forecast